DK268588A - Syntetisk peptidantigen til detektering af hiv-2-infektion - Google Patents

Syntetisk peptidantigen til detektering af hiv-2-infektion

Info

Publication number
DK268588A
DK268588A DK268588A DK268588A DK268588A DK 268588 A DK268588 A DK 268588A DK 268588 A DK268588 A DK 268588A DK 268588 A DK268588 A DK 268588A DK 268588 A DK268588 A DK 268588A
Authority
DK
Denmark
Prior art keywords
hiv
infection
antigen
detecting hiv
synthetic
Prior art date
Application number
DK268588A
Other languages
Danish (da)
English (en)
Other versions
DK268588D0 (da
Inventor
Peter Horal
Stig Jeansson
Lars Rymo
Bo Svennerholm
Anders Vahlne
Original Assignee
Virovahl Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Virovahl Sa filed Critical Virovahl Sa
Publication of DK268588D0 publication Critical patent/DK268588D0/da
Publication of DK268588A publication Critical patent/DK268588A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/22—Viral peptide or viral protein
    • Y10S930/221—Retrovirus related, or human immunodeficiency virus related, or simian immunodeficiency virus related

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Virology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DK268588A 1987-05-18 1988-05-17 Syntetisk peptidantigen til detektering af hiv-2-infektion DK268588A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/051,727 US4812556A (en) 1987-05-18 1987-05-18 Synthetic peptide antigen for the detection of HIV-2 infection

Publications (2)

Publication Number Publication Date
DK268588D0 DK268588D0 (da) 1988-05-17
DK268588A true DK268588A (da) 1988-11-19

Family

ID=21973023

Family Applications (1)

Application Number Title Priority Date Filing Date
DK268588A DK268588A (da) 1987-05-18 1988-05-17 Syntetisk peptidantigen til detektering af hiv-2-infektion

Country Status (11)

Country Link
US (1) US4812556A (de)
EP (1) EP0292454B1 (de)
AT (1) ATE83247T1 (de)
AU (1) AU606951B2 (de)
DE (1) DE3876496T2 (de)
DK (1) DK268588A (de)
ES (1) ES2011334A6 (de)
FI (1) FI882173A (de)
NO (1) NO881719L (de)
NZ (1) NZ224581A (de)
ZA (1) ZA883431B (de)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8701628D0 (sv) * 1987-04-16 1987-04-16 Erling Norrby Medel for analys mm
US5019387A (en) * 1987-09-08 1991-05-28 Duke University Production of antibodies to HIV
SE8704185L (sv) * 1987-10-28 1989-04-29 Ferring Ab Nya peptider, artificiella antigener och immunoanalystestsatser
ES2054769T3 (es) * 1987-11-16 1994-08-16 Hoffmann La Roche Polipeptidos hiv-2 recombinantes.
US5780038A (en) * 1987-11-16 1998-07-14 Roche Diagnostic Systems, Inc. HIV-2 envelope polypeptides
US6214537B1 (en) * 1988-01-27 2001-04-10 Biochem Immunosystems, Inc. Synthetic peptides and mixtures thereof for detecting HIV antibodies
US6210874B1 (en) 1988-01-27 2001-04-03 Biochem Immunosystems, Inc. Synthetic peptides and mixtures thereof for detecting HIV antibodies
US5241047A (en) * 1988-12-08 1993-08-31 Biochem Pharma Inc. Synthetic peptides and mixtures thereof for detecting HIV antibodies
JPH03504722A (ja) * 1988-04-07 1991-10-17 ザ　トラスティーズ　オブ　ザ　ユニバーシティー　オブ　アラバマ Ｈｉｖ誘導細胞融合およびシンシチウム形成に対するペプチド阻害剤
EP0362927A3 (de) * 1988-10-06 1990-11-14 Akzo N.V. Mit HIV-Antikörpern immunochemisch reaktive synthetische Polypeptide
US5260189A (en) * 1988-12-20 1993-11-09 Immunodiagnostics, Inc. Synthetic HIV-like peptides their compositions and uses
JP2994031B2 (ja) * 1988-12-20 1999-12-27 クラリティ テクノロジーズ インコーポレイテッド Ｈｉｖ−１又はｈｉｖ−２抗体の存在又は量の確定方法、免疫特異的試薬、合成ペプチド、診断用キット、ｈｉｖ−１又はｈｉｖ−２抗体の調製方法、免疫原及び抗体
CA2017021A1 (en) * 1989-05-22 1990-11-22 Johannes Jacobus Schalken Diagnostic test for detecting antibodies directed against antigens of one or more related viruses
JPH0338599A (ja) * 1989-07-05 1991-02-19 Calpis Food Ind Co Ltd:The 抗ｈｉｖペプチド及び抗ｈｉｖ修飾ペプチド
US6083504A (en) * 1989-08-24 2000-07-04 Bioclonetics Incorporated Human monoclonal antibodies directed against the transmembrane glycoprotein (GP41) of human immunodeficiency virus-1 (HIV-1)
US5459060A (en) * 1989-08-24 1995-10-17 Bioclonetics Incorporated Human monoclonal antibodies directed against the transmembrane glycoprotein (gp41) of human immunodeficiency virus-1 (HIV-1)
US6008044A (en) * 1989-08-24 1999-12-28 Bioclonetics Human monoclonal antibodies directed against the transmembrane glycoprotein (gp41) of human immunodeficiency virus-1 (HIV-1) and detection of antibodies against epitope (GCSGKLIC)
ATE164853T1 (de) * 1990-01-16 1998-04-15 Orgenics Ltd Peptide, von virus-hiv-hüllen-glycoproteinen abstammend, deren verwendung zum nachweis einer infektion dieser viren und für die impfung gegen aids
FR2657016B1 (fr) * 1990-01-16 1995-08-25 Clonatec Sa Peptides derivant de la glycoproteine d'enveloppe du virus-hiv-2, leurs applications a la detection d'une infection due a ce virus et a la vaccination contre le sida.
CA2099367A1 (en) * 1991-11-04 1993-05-05 Dade International Inc. Synthetic peptides corresponding to portions of hiv-2 virus and methods of using in an improved assay
US6274552B1 (en) 1993-03-18 2001-08-14 Cytimmune Sciences, Inc. Composition and method for delivery of biologically-active factors
US5420244A (en) * 1993-08-06 1995-05-30 The United States Of America As Represented By The Department Of Health And Human Services Methods and compositions for diagnosing HTLV-I associated myelopathy and adult T-cell leukemia
US20010055581A1 (en) * 1994-03-18 2001-12-27 Lawrence Tamarkin Composition and method for delivery of biologically-active factors
US6407218B1 (en) * 1997-11-10 2002-06-18 Cytimmune Sciences, Inc. Method and compositions for enhancing immune response and for the production of in vitro mabs
US7229841B2 (en) * 2001-04-30 2007-06-12 Cytimmune Sciences, Inc. Colloidal metal compositions and methods
US6537631B1 (en) * 1999-04-30 2003-03-25 Kimberly-Clark Worldwide, Inc. Roll of wet wipes
WO2003021339A2 (en) * 2001-09-04 2003-03-13 Wisconsin Alumni Research Foundation Liquid crystal switching mechanism
EP1438433A4 (de) * 2001-10-04 2005-12-21 Wisconsin Alumni Res Found Nachweis der hybridisierung von dna auf oberflächen
US7807348B2 (en) * 2002-03-20 2010-10-05 Wisconsin Alumni Research Foundation Optical imaging of nanostructured substrates
US7125592B2 (en) * 2002-04-10 2006-10-24 Wisconsin Alumni Research Foundation Detecting interactions at biomimetic interfaces with liquid crystals
WO2004044583A1 (en) * 2002-11-08 2004-05-27 Wisconsin Alumni Research Foundation Surfaces with gradients in surface topography
WO2005010160A2 (en) * 2003-07-17 2005-02-03 Wisconsin Alumni Research Foundation Liquid crystals with reduced toxicity and applications thereof
JP2008504216A (ja) * 2003-12-02 2008-02-14 サイトイミューン サイエンシズ インコーポレイテッド モノクローナル抗体の生成のための方法および組成物
CA2554755A1 (en) * 2004-01-28 2005-08-11 Cytimmune Sciences, Inc. Functionalized colloidal metal compositions and methods
WO2007111681A2 (en) * 2005-10-31 2007-10-04 Wisconsin Alumni Research Foundation Device and methods for liquid crystal-based bioagent detection
US20110014118A1 (en) * 2007-09-21 2011-01-20 Lawrence Tamarkin Nanotherapeutic colloidal metal compositions and methods
EP2200932A4 (de) * 2007-09-21 2014-09-10 Cytimmune Sciences Inc Nanotherapeutische kolloidale metallzusammensetzungen und verfahren
US7960145B2 (en) * 2007-11-08 2011-06-14 Cytimmune Sciences, Inc. Compositions and methods for generating antibodies
US20130306629A1 (en) * 2012-05-21 2013-11-21 Hanna Asfaw Unity Cup

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ219024A (en) * 1986-01-22 1990-04-26 Pasteur Institut Hiv-2 retrovirus protein and nucleic acid sequences and detection methods

Also Published As

Publication number Publication date
US4812556A (en) 1989-03-14
EP0292454A2 (de) 1988-11-23
ZA883431B (en) 1988-11-17
AU606951B2 (en) 1991-02-21
ATE83247T1 (de) 1992-12-15
AU1645688A (en) 1988-11-24
DE3876496T2 (de) 1993-05-13
EP0292454A3 (en) 1989-10-04
NZ224581A (en) 1990-09-26
EP0292454B1 (de) 1992-12-09
NO881719L (no) 1988-11-21
FI882173A (fi) 1988-11-19
ES2011334A6 (es) 1990-01-01
NO881719D0 (no) 1988-04-21
DK268588D0 (da) 1988-05-17
DE3876496D1 (de) 1993-01-21
FI882173A0 (fi) 1988-05-10

Similar Documents

Publication Publication Date Title
DK268588A (da) Syntetisk peptidantigen til detektering af hiv-2-infektion
FI904345A0 (fi) Syntetisk peptidantigen foer detektering av htlv-1 infektion.
ES2013328A6 (es) Un metodo para detectar anticuerpos contra antigenos hiv-1.
DK0891982T3 (da) HIV-peptider
DE69013950D1 (de) Monoklonaler Antikörper zur Unterscheidung HIV-2-seropositiver von HIV-1-seropositiven Individuen.
NO173958C (no) Fremgangsmaate for paavisning av tilstedevaerelse av antistoff mot HIV-virus
ATE67313T1 (de) Nachweis von menschlichem cytomegalovirusspezifischem igm.
SE8902148D0 (sv) Syntetiska peptid antigen foer detektion av htlv-1 infektion
DE3672624D1 (de) Verfahren zum nachweis von htlv-iii neutralisierenden antikoerpern in sera.
GR3033885T3 (en) Synthetic antigens for the detection of aids-related disease caused by LAV-2.
ATE119203T1 (de) Monoklonale antikörper von mäusen gegen das gp41 protein von menschlichem immunmangelsyndrom- virus.
DE3579856D1 (de) Immunulogischer test zur bestimmung von gemeinsamen, bestimmenden hepatitis-b-antikoerpern.
DE69026875D1 (de) Immunobestimmung von menschlichem osteocalcin, reagenz und satz dafür
SE8701294D0 (sv) Hiv-peptid

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment